Laparoscopic Compared With Open Surgery for Severe Pelvic Inflammatory Disease and Tubo-Ovarian Abscess.


Journal

Obstetrics and gynecology
ISSN: 1873-233X
Titre abrégé: Obstet Gynecol
Pays: United States
ID NLM: 0401101

Informations de publication

Date de publication:
06 2019
Historique:
entrez: 29 5 2019
pubmed: 29 5 2019
medline: 25 2 2020
Statut: ppublish

Résumé

To compare operative outcomes of laparoscopic surgery compared with laparotomy in patients with moderate to severe pelvic inflammatory disease (PID). Using the Diagnosis Procedure Combination database, a national inpatient database for acute-care inpatients in Japan, we performed a large, nationwide retrospective cohort study. We identified all patients aged 18 years or older who were diagnosed with PID with or without tubo-ovarian abscess and were admitted to a participating hospital from July 2010 to March 2016. We excluded patients who were pregnant, had cancer, or for whom data were missing. We compared outcomes between patients who underwent laparoscopic surgery compared with laparotomy. Propensity score-matched analyses were performed to compare operative outcomes including postoperative length of stay, surgical complications, in-hospital deaths, and revision surgery. Of 27,841 patients with PID, 4,419 (15.9%) underwent surgical intervention. From among 749 women undergoing laparoscopy and 3,670 women undergoing laparotomy for PID, 740 pairs were created for propensity score matching. The laparoscopic group had shorter operation duration (125 vs 166 min), fewer blood transfusions (4.7% vs 10.0%), and shorter length of hospital stay (median 5 days vs 7 days; all P<.001) compared with the laparotomy group. There were no significant differences between groups for in-hospital deaths, surgical complications, and revision surgery. Laparoscopic surgery may have clinical advantages over laparotomy in patients diagnosed with severe PID.

Identifiants

pubmed: 31135738
doi: 10.1097/AOG.0000000000003259
pii: 00006250-201906000-00021
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1224-1230

Références

Sutton MY, Sternberg M, Zaidi A, St Louis ME, Markowitz LE. Trends in pelvic inflammatory disease hospital discharges and ambulatory visits, United States, 1985–2001. Sex Transm Dis 2005;32:778–84.
Centers for Disease Control. PID fact sheet. Atlanta (GA): Department of Health and Human Services; 2007.
Wiesenfeld HC, Sweet RL. Progress in the management of tuboovarian abscesses. Clin Obstet Gynecol 1993;36:433–44.
McNeeley SG, Hendrix SL, Mazzoni MM, Kmak DC, Ransom SB. Medically sound, cost-effective treatment for pelvic inflammatory disease and tuboovarian abscess. Am J Obstet Gynecol 1998;178:1272–8.
Mollen CJ, Pletcher JR, Bellah RD, Lavelle JM. Prevalence of tubo-ovarian abscess in adolescents diagnosed with pelvic inflammatory disease in a pediatric emergency department. Pediatr Emerg Care 2006;22:621–5.
Güngördük K, Guzel E, Asicioğlu O, Yildirim G, Ataser G, Ark C, et al. Experience of tubo-ovarian abscess in western Turkey. Int J Gynaecol Obstet 2014;124:45–50.
Lareau SM, Beigi RH. Pelvic inflammatory disease and tubo-ovarian abscess. Infect Dis Clin North Am 2008;22:693–708.
Reed SD, Landers DV, Sweet RL. Antibiotic treatment of tuboovarian abscess: comparison of broad-spectrum beta-lactam agents versus clindamycin-containing regimens. Am J Obstet Gynecol 1991;164:1556–61.
Rivlin ME, Hunt JA. Ruptured tuboovarian abscess: is hysterectomy necessary? Obstet Gynecol 1977;50:518–22.
Pedowitz P, Bloomfield RD. Ruptured adnexal abscess (tuboovarian) with generalized peritonitis. Am J Obstet Gynecol 1964;88:721–9.
Mickal A, Sellmann AH. Management of tubo-ovarian abscess. Clin Obstet Gynecol 1969;12:252–64.
Centers for Disease Control and Prevention. Pelvic inflammatory disease (PID)—CDC fact sheet. Available at: https://www.cdc.gov/std/pid/stdfact-pid-detailed.htm. Retrieved February 15, 2019.
Minakami H, Hiramatsu Y, Koresawa M, Fujii T, Hamada H, Iitsuka Y, et al. Guidelines for obstetrical practice in Japan: Japan society of Obstetrics and Gynecology (JSOG) and Japan Association of Obstetricians and Gynecologists (JAOG) 2011 edition. J Obstet Gynaecol Res 2011;37:1174–97.
Minakami H, Maeda T, Fujii T, Hamada H, Iitsuka Y, Itakura A, et al. Guidelines for obstetrical practice in Japan: Japan society of Obstetrics and Gynecology (JSOG) and Japan Association of Obstetricians and Gynecologists (JAOG) 2014 edition. J Obstet Gynaecol Res 2014;40:1469–99.
Workowski KA, Bolan GA; Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 2015;64:1–137.
Ross J, Guaschino S, Cusini M, Jensen J. 2017 European guideline for the management of pelvic inflammatory disease. Int J STD AIDS 2018;29:108–14.
Sexual Health Society of Victoria. National management guidelines for pelvic inflammatory disease. Available at: https://www.mshc.org.au/HealthProfessional/MSHCTreatmentGuidelines/PelvicInflammatoryDisease(PID)#.W3UoCZP7Sb9. Retrieved February 15, 2019.
Clinical Effectiveness Group, British Association for Sexual Health and HIV. UK national guideline for the management of pelvic inflammatory disease 2011. Available at: https://www.bashh.org/documents/3572.pdf. Retrieved February 15, 2019.
Yang CC, Chen P, Tseng JY, Wang PH. Advantages of open laparoscopic surgery over exploratory laparotomy in patients with tubo-ovarian abscess. J Am Assoc Gynecol Laparosc 2002;9:327–32.
Roberts W, Dockery JL. Operative and conservative treatment of tubo-ovarian abscess due to pelvic inflammatory disease. South Med J 1984;77:860–3.
Chu L, Ma H, Liang J, Li L, Shen A, Wang J, et al. Effectiveness and adverse events of early laparoscopic therapy versus conservative treatment for tubo-ovarian or pelvic abscess: a single-center retrospective cohort study. Gynecol Obstet Invest 2019;4:1–9.
Matsui H, Jo T, Fushimi K, Yasunaga H. Outcomes after early and delayed rehabilitation for exacerbation of chronic obstructive pulmonary disease: a nationwide retrospective cohort study in Japan. Respir Res 2017;18:68.
Yamana H, Moriwaki M, Horiguchi H, Kodan M, Fushimi K, Yasunaga H. Validity of diagnoses, procedures, and laboratory data in Japanese administrative data. J Epidemiol 2017;27:476–82.
Tagami T, Matsui H, Fushimi K, Yasunaga H. Validation of the prognostic burn index: a nationwide retrospective study. Burns 2015;41:1169–75.
Tagami T, Matsui H, Fushimi K, Yasunaga H. Prophylactic antibiotics may improve outcome in patients with severe burns requiring mechanical ventilation: propensity score analysis of a Japanese nationwide database. Clin Infect Dis 2016;62:60–6.
Austin PC. Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat 2011;10:150–61.
Austin PC. Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research. Commun Stat Simul Comput 2009;38:1228–34.
Molander P, Cacciatore B, Sjöberg J, Paavonen J. Laparoscopic management of suspected acute pelvic inflammatory disease. J Am Assoc Gynecol Laparosc 2000;7:107–10.
Goh WC, Beh ST, Chern B, Yap LK. A three year review on surgical treatment of tubo-ovarian abscess. Med J Malaysia 2002;57:292–7.
Elizur SE, Lebovitz O, Weintraub AY, Eisenberg VH, Seidman DS, Goldenberg M, et al. Pelvic inflammatory disease in women with endometriosis is more severe than in those without. Aust N Z J Obstet Gynaecol 2014;54:162–5.
Booth M, Beral V, Maconochie N, Carpenter L, Scott C. A case-control study of benign ovarian tumours. J Epidemiol Community Health 1992;46:528–31.
Terao M, Koga K, Fujimoto A, Wada-Hiraike O, Osuga Y, Yano T, et al. Factors that predict poor clinical course among patients hospitalized with pelvic inflammatory disease. J Obstet Gynaecol Res 2014;40:495–500.
Kaplan AL, Jacobs WM, Ehresman JB. Aggressive management of pelvic abscess. Am J Obstet Gynecol 1967;98:482–7.
Landers DV, Sweet RL. Tubo-ovarian abscess: contemporary approach to management. Rev Infect Dis 1983;5:876–84.
Ginsburg DS, Stern JL, Hamod KA, Genadry R, Spence MR. Tubo-ovarian abscess: a retrospective review. Am J Obstet Gynecol 1980;138:1055–8.
Sweet RL. Pelvic inflammatory disease. In: Sweet RL, Gibbs RS, editors. Infectious diseases of the female genital tract. 5th ed. Philadelphia (PA): Lippincott Williams and Wilkins; 2009:220–44.

Auteurs

Daisuke Shigemi (D)

Department of Clinical Epidemiology and Health Economics, School of Public Health, the University of Tokyo, and the Department of Health Policy and Informatics, Tokyo Medical and Dental University Graduate School, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH